These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8456079)

  • 1. Influence of dose range on degree of nonlinearity detected in dose-proportionality studies for drugs with saturable elimination: single-dose and steady-state studies.
    Shepard TA; Lordi N; Sparrow PE
    Pharm Res; 1993 Feb; 10(2):289-93. PubMed ID: 8456079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Input rate-dependent stereoselective pharmacokinetics: effect of pulsatile oral input.
    Mehvar R
    Chirality; 1994; 6(3):185-95. PubMed ID: 8024949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
    Wagner JG
    Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(5):513-28. PubMed ID: 2804255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2004; 29(3):205-14. PubMed ID: 15537173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Michaelis-Menten kinetics determine cyclosporine steady-state concentrations: a population analysis in kidney transplant patients.
    Grevel J; Post BK; Kahan BD
    Clin Pharmacol Ther; 1993 Jun; 53(6):651-60. PubMed ID: 8513657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steady-state characteristics and optimal dosage regimens for Michaelis-Menten elimination drugs].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):61-5. PubMed ID: 7657342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM; Islam SI
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.
    Veng-Pedersen P; Widness JA; Pereira LM; Peters C; Schmidt RL; Lowe LS
    J Pharm Sci; 1995 Jun; 84(6):760-7. PubMed ID: 7562419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
    Fujimiya T; Fukui Y; Komura S
    Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A minimax approach to the single-point method of drug dosing.
    Bahn MM; Landaw EM
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):255-69. PubMed ID: 3668803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
    Da Ros L; Squassante L; Milleri S
    Clin Pharmacokinet; 2003; 42(1):99-106. PubMed ID: 12489980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical Solution and Exposure Analysis of a Pharmacokinetic Model with Simultaneous Elimination Pathways and Endogenous Production: The Case of Multiple Dosing Administration.
    Wu X; Nekka F; Li J
    Bull Math Biol; 2019 Sep; 81(9):3436-3459. PubMed ID: 31420841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.
    Poulin P; Theil FP
    J Pharm Sci; 2002 Jan; 91(1):129-56. PubMed ID: 11782904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.